Online Reporting Tool

National Target

General

Government

Burkina Faso

Enter national target title

Mise en œuvre des mesures de biotechnologies

Description

D'ici à 2030, créer et renforcer les capacités aux fins de l’application des mesures relatives à la sécurité biotechnologique prévues à l'article 8 g), de la Convention sur la diversité biologique, ainsi que des mesures relatives à la gestion des biotechnologies et au partage de leurs avantages prévues à l’article 19 de celle-ci.

Please outline the main policy measures or actions that will be taken to achieve this national target.

Promotion des biotechnologies modernes

Renforcement du cadre juridique

Alignment

Contribution to global Goals

GBF-G-A. Ecosystems are conserved, extinctions are halted and genetic diversity is maintained

GBF-G-B. Biodiversity is sustainably used and its contributions to people are maintained, enhanced or restored

GBF-G-C. Benefits from the use of genetic resources are shared and substantially increased

GBF-G-D. The biodiversity funding gap of 700 billion USD is progressively closed by ensuring adequate means of implementation are available.

Alignment with global targets

Global Targets

Degree of Alignment

GBF-T17. Strengthen biosafety and distribute benefits of biotechnology

High

Which of the “considerations for implementation” in Section C of the GBF have been taken into account in developing this national target, and the actions to implement it

Biodiversity and health

Collective effort towards the targets

Consistency with international agreements or instruments

Cooperation and synergies

Fulfilment of the three objectives of the Convention and its Protocols, and their balanced implementation

Intergenerational equity

National circumstances, priorities and capabilities

Right to development

Science and innovation

Whole-of-government and whole-of-society approach

Explanation, including which aspects of the goal or target are covered

Les connaissances sur les ressources biologiques

Le cadre politique et juridique en matière de diversité biologique

Indicators to be used to monitor this national target

Headline indicators

A.1 Red List of Ecosystems

A.2 Extent of natural ecosystems

A.3 Red List Index

A.4 Proportion of populations within species with an effective population size greater than 500

B.1 Services provided by ecosystems

C.1 Monetary benefits received in accordance with applicable internationally agreed access and benefit-sharing instruments

C.2 Non-monetary benefits arising from applicable international access and benefit-sharing instruments

D.1 International public funding, including official development assistance for conservation and sustainable use of biodiversity and ecosystems

D.2 Domestic public funding on conservation and sustainable use of biodiversity and ecosystems

D.3 Private funding (domestic and international) on conservation and sustainable use of biodiversity and ecosystems

Binary indicators

13.b Number of countries that have taken effective legal, policy, administrative and capacity-building measures at all levels, as appropriate, to ensure the fair and equitable sharing of benefits from the utilization of genetic resources and from digital sequence information on genetic resources, as well as traditional knowledge associated with genetic resources

17.b Number of countries that have taken action to implement biosafety measures as set out in Article 8(g) of the Convention and measures for the handling of biotechnology and the distribution of its benefits as set out in Article 19

B.b Number of countries with policies or actions for implementing and monitoring the sustainable use of biodiversity and the maintenance and enhancement of nature’s contributions to people, including ecosystem functions and services

Other national indicators

Nombre de parties prenantes formés en matière d’analyse des risques dans la mise en œuvre du protocole de Cartagena sur la prévention des risques biotechnologiques

Nombre d'OGM autorisé par l'Agence Nationale de Biosécurité

Nombre d'OGM non autorisé détecté par l'Agence Nationale de Biosécurité

Nombre de spéculations analysées pour la recherche d'OGM non autorisés

Means to implementation and barriers to implementation

Please indicate if additional means of implementation are needed for the attainment of this national target.

Yes (Additional means of implementation are needed for the attainment of this national target)

Please explain (Additional means of implementation are needed for the attainment of this national target)

Transfert de technologie, Renforcement des capacités et moyens financiers